Premature Ovarian Failure and Fertility in Long-Term Survivors of Hodgkin's Lymphoma: A European Organisation for Research and Treatment of Cancer Lymphoma Group and Groupe d'Etude des Lymphomes de l'Adulte Cohort StudyVAN DER KAAIJ, Marleen A. E; HEUTTE, Natacha; ALEMAN, Berthe M. P et al.Journal of clinical oncology. 2012, Vol 30, Num 3, pp 291-299, issn 0732-183X, 9 p.Article

Anémie et chimiothérapie = Anemia and chemotherapyRAY-COQUARD, Isabelle; BACHELOT, Thomas; SEBBAN, Catherine et al.Bulletin du cancer. 2003, Vol 90, pp 133-143, issn 0007-4551, 11 p., NSArticle

Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trialSALLES, Gilles; SEYMOUR, John Francis; CABALLERO, Dolores et al.Lancet (British edition). 2011, Vol 377, Num 9759, pp 42-51, issn 0140-6736, 10 p.Article

Efficacy and Safety of the Combination of Rituximab, Fludarabine, and Mitoxantrone for Rituximab-Naive, Recurrent/Refractory Follicular Non-Hodgkin Lymphoma With High Tumor Burden: A Multicenter Phase 2 Trial by the Groupe d'Etude des Lymphomes de l'Adulte (GELA) and Groupe Ouest Est des Leucémies et Autres Maladies du Sang (GOELAMS)MORSCHHAUSER, Franck; MOUNIER, Nicolas; SEBBAN, Catherine et al.Cancer. 2010, Vol 116, Num 18, pp 4299-4308, issn 0008-543X, 10 p.Article

Rituximab plus CHOP (R-CHOP) overcomes bcl-2-associated resistance to chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL)MOUNIER, Nicolas; BRIERE, Josette; BOUABDALLAH, Reda et al.Blood. 2003, Vol 101, Num 11, pp 4279-4284, issn 0006-4971, 6 p.Article

Achievement of VGPR to induction therapy is an important prognostic factor for longer PFS in the IFM 2005-01 trialMOREAU, Philippe; ATTAL, Michel; KETTERER, Nicolas et al.Blood. 2011, Vol 117, Num 11, pp 3041-3044, issn 0006-4971, 4 p.Article

Bortezomib plus dexamethasone versus reduced-dose bortezomib, thalidomide plus dexamethasone as induction treatment before autologous stem cell transplantation in newly diagnosed multiple myelomaMOREAU, Philippe; AVET-LOISEAU, Herve; LEPEU, Gerard et al.Blood. 2011, Vol 118, Num 22, pp 5752-5758, issn 0006-4971, 7 p.Article

Impact of Rituximab and/or High-Dose Therapy With Autotransplant at Time of Relapse in Patients With Follicular Lymphoma : A GELA StudySEBBAN, Catherine; BRICE, Pauline; COIFFIER, Bertrand et al.Journal of clinical oncology. 2008, Vol 26, Num 21, pp 3614-3620, issn 0732-183X, 7 p.Article

CD4 lymphopenia to identify end-of-life metastatic cancer patientsPERON, Julien; CROPET, Claire; LABIDI GALY, Inthidar et al.European journal of cancer (1990). 2013, Vol 49, Num 5, pp 1080-1089, issn 0959-8049, 10 p.Article

Hepatic veno-occlusive disease after tandem autologous stem cell transplantation conditioned by melphalanINTIDHAR LABIDI, Sana; SEBBAN, Catherine; GHESQUIERES, Herve et al.International journal of hematology. 2008, Vol 88, Num 3, pp 291-293, issn 0925-5710, 3 p.Article

Phase III Trial of Consolidation Therapy With Yttrium-90-Ibritumomab Tiuxetan Compared With No Additional Therapy After First Remission in Advanced Follicular LymphomaMORSCHHAUSER, Franck; RADFORD, John; PETRINI, Mario et al.Journal of clinical oncology. 2008, Vol 26, Num 32, pp 5156-5164, issn 0732-183X, 9 p.Article

CD4 lymphopenia as a risk factor for febrile neutropenia and early death after cytotoxic chemotherapy in adult patients with cancerBORG, Christophe; RAY-COQUARD, Isabelle; PHILIP, Irene et al.Cancer. 2004, Vol 101, Num 11, pp 2675-2680, issn 0008-543X, 6 p.Article

Anémie et chimiothérapie = Anemia and chemotherapyRAY-COQUARD, Isabelle; BACHELOT, Thomas; SEBBAN, Catherine et al.Bulletin du cancer. 2003, Vol 90, pp S133-S143, issn 0007-4551, NSArticle

Addition of Rituximab to Chlorambucil Produces Superior Event-Free Survival in the Treatment of Patients With Extranodal Marginal-Zone B-Cell Lymphoma: 5-Year Analysis of the IELSG-19 Randomized StudyZUCCA, Emanuele; CONCONI, Annarita; PILERI, Stefano A et al.Journal of clinical oncology. 2013, Vol 31, Num 5, pp 565-572, issn 0732-183X, 8 p.Article

Parenthood in Survivors of Hodgkin Lymphoma: An EORTC-GELA General Population Case-Control StudyDER KAAIJ, Marleen A. E. Van; HEUTTE, Natacha; LUGTENBURG, Pieternella J et al.Journal of clinical oncology. 2012, Vol 30, Num 31, pp 3854-3863, issn 0732-183X, 10 p.Article

Lymphopenia as a Prognostic Factor for Overall Survival in Advanced Carcinomas, Sarcomas, and LymphomasRAY-COQUARD, Isabelle; CROPET, Claire; GUASTAILA, Jean-Paul et al.Cancer research (Chicago, Ill.). 2009, Vol 69, Num 13, pp 5383-5391, issn 0008-5472, 9 p.Article

Rituximab combined with chemotherapy and interferon in follicular lymphoma patients : results of the GELA-GOELAMS FL2000 studySALLES, Gilles; MOUNIER, Nicolas; AUDHUY, Bruno et al.Blood. 2008, Vol 112, Num 13, pp 4824-4831, issn 0006-4971, 8 p.Article

Rituximab (anti-CD20 monoclonal antibody) as single first-line therapy for patients with follicular lymphoma with a low tumor burden : clinical and molecular evaluationCOLOMBAT, Philippe; SALLES, Gilles; STAMATOULLAS, Astasia et al.Blood. 2001, Vol 97, Num 1, pp 101-106, issn 0006-4971Article

Adult acute lymphocytic leukemia study testing chemotherapy and autologous and allogeneic transplantation : A follow-up report of the French Protocol LALA 87THIEBAUT, Anne; VERNANT, Jean Paul; DEGOS, Laurent et al.Hematology/oncology clinics of North America. 2000, Vol 14, Num 6, issn 0889-8588, x,1353-1366 [15 p.]Article

Translocation t(14;16) and multiple myeloma: is it really an independent prognostic factor?HERVEAVET-LOISEAU; MALARD, Florent; MICHALLET, Mauricette et al.Blood. 2011, Vol 117, Num 6, pp 2009-2011, issn 0006-4971, 3 p.Article

Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'AdulteCOIFFIER, Bertrand; THIEBLEMONT, Catherine; BELHADJ, Karim et al.Blood. 2010, Vol 116, Num 12, pp 2040-2045, issn 0006-4971, 6 p.Article

Risk-Adapted Salvage Treatment With Single or Tandem Autologous Stem-Cell Transplantation for First Relapse/ Refractory Hodgkin's Lymphoma : Results of the Prospective Multicenter H96 Trial by the GELA/SFGM Study GroupMORSCHHAUSER, Franck; BRICE, Pauline; BOUABDALLAH, Krimo et al.Journal of clinical oncology. 2008, Vol 26, Num 36, pp 5980-5987, issn 0732-183X, 8 p.Article

Traitements anti-VEGF : un emploi universel ? = Are antiangiogenic antibodies universal for solid tumor?RAY-COQUARD, Isabelle; BACHELOT, Thomas; BLAY, Jean-Yves et al.Bulletin du cancer. 2007, Vol 94, Num JUIL, issn 0007-4551, S191-S196, NSArticle

Facteurs pronostiques des neutropénies fébriles : Facteurs de croissance hématopoïétique : nouvelles modalités d'utilisation = Prognostic factors for febrile neutropeniaRAY-COQUARD, Isabelle; BORG, Christophe; BIRON, Pierre et al.Bulletin du cancer. 2006, Vol 93, Num 5, pp 501-506, issn 0007-4551, 6 p.Article

Standard chemotherapy with interferon compared with CHOP followed by high-dose therapy with autologous stem cell transplantation in untreated patients with advanced follicular lymphoma : the GELF-94 randomized study from the groupe d'etude des lymphomes de l'adulte (GELA). CommentaryVAN BESIEN, Koen; SEBBAN, Catherine; DOYEN, Chantal et al.Blood. 2006, Vol 108, Num 8, issn 0006-4971, 2496-2497,2540-2544 [7 p.]Article